BCAX
Bicara Therapeutics Inc. Common Stock
NASDAQ: BCAX · HEALTHCARE · BIOTECHNOLOGY
$21.58
+1.41% today
Updated 2026-04-30
Market cap
$1.40B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.52
Dividend yield
—
52W range
$8 – $24
Volume
0.6M
Bicara Therapeutics Inc. Common Stock (BCAX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-30.90%
ROA
-20.70%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2022 | $0.00 | $-37.84M | — | — | — |
| 2023 | $0.00 | $-51.98M | — | — | — |
| 2024 | $0.00 | $-68.00M | — | — | — |
| 2025 | $0.00 | $-137.95M | — | — | — |